Indivior Pharmaceuticals, Inc. (DELISTED) (INDV:DL)
36.28
+0.91
(+2.57%)
USD |
NASDAQ |
Nov 02, 16:00
Indivior Pharmaceuticals Price : 36.28 for Nov. 2, 2026
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Nov 02, 2026 | 35.43 | 37.02 | 35.32 | 36.28 | 4.869M |
| Oct 30, 2026 | 34.78 | 36.49 | 34.62 | 35.37 | 4.607M |
| Oct 29, 2026 | 36.53 | 37.00 | 34.53 | 35.25 | 5.720M |
| Oct 28, 2026 | 34.39 | 34.86 | 33.84 | 34.77 | 1.530M |
| Oct 27, 2026 | 34.68 | 34.82 | 33.93 | 34.72 | 2.411M |
| Oct 26, 2026 | 34.47 | 34.65 | 33.99 | 34.56 | 916793.0 |
| Oct 23, 2026 | 35.34 | 35.34 | 34.10 | 34.47 | 1.484M |
| Oct 22, 2026 | 34.77 | 35.36 | 34.54 | 35.33 | 871703.0 |
| Oct 21, 2026 | 34.92 | 35.15 | 34.56 | 34.79 | 3.345M |
| Oct 20, 2026 | 34.02 | 35.12 | 33.80 | 34.77 | 1.925M |
| Oct 19, 2026 | 32.60 | 34.19 | 32.48 | 33.87 | 2.276M |
| Oct 16, 2026 | 33.47 | 33.84 | 32.31 | 32.45 | 4.291M |
| Oct 15, 2026 | 34.57 | 34.86 | 33.54 | 33.62 | 1.751M |
| Oct 14, 2026 | 35.11 | 36.30 | 33.99 | 34.16 | 2.781M |
| Oct 13, 2026 | 36.09 | 36.26 | 35.19 | 35.42 | 1.931M |
| Oct 12, 2026 | 36.00 | 36.32 | 35.37 | 36.06 | 7.474M |
| Oct 09, 2026 | 35.45 | 36.14 | 35.21 | 35.83 | 4.800M |
| Oct 08, 2026 | 35.72 | 36.35 | 34.85 | 35.45 | 1.527M |
| Oct 07, 2026 | 35.58 | 36.30 | 35.58 | 36.13 | 1.770M |
| Oct 06, 2026 | 35.96 | 36.15 | 35.03 | 35.90 | 2.391M |
| Oct 05, 2026 | 36.00 | 36.26 | 35.73 | 35.99 | 3.003M |
| Oct 02, 2026 | 35.46 | 36.15 | 35.26 | 35.71 | 1.669M |
| Oct 01, 2026 | 35.85 | 36.20 | 35.25 | 35.38 | 1.879M |
| Sep 30, 2026 | 36.54 | 36.60 | 35.79 | 35.85 | 1.674M |
| Sep 29, 2026 | 36.74 | 37.05 | 36.08 | 36.59 | 2.005M |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Supernus Pharmaceuticals, Inc. | 28.15 |
| Bristol Myers Squibb Co. | 61.71 |
| Eli Lilly & Co. | 1409.38 |
| Ligand Pharmaceuticals, Inc. | 313.52 |
| Amneal Pharmaceuticals, Inc. | 20.21 |
Price Related Metrics
| PE Ratio | 10.04 |
| PS Ratio | 3.301 |
| PEG Ratio | 0.0391 |
| Price to Free Cash Flow | 174.59 |
| Earnings Yield | 9.96% |
| Market Cap | 4.281B |
| Operating PE Ratio | 7.326 |
| Normalized PE Ratio | 8.857 |